Letter to FDA on Premarket Review Disclosure
In light of the skyrocketing youth e-cigarette epidemic, and concerns that smoking and vaping may increase the risk of severe complications from COVID-19, it is more critical than ever that new tobacco products be subject to statutorily-required public health review by the Food and Drug Administration [More]

